Company / Current Liabilities per Share
Larimar Therapeutics, Inc. Current Liabilities per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.33
FY2019
5-year range
$0.27 / $0.72
FY2015-FY2019
Trend
-32.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.27 to $0.33 over the past 2 years.
Based on SEC 10-K filings.
0.33 in FY2019 with a 5-year CAGR of -49.0%.
Increased from $0.27 to $0.33 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- -49.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, current liabilities per share decreased 32.5% year-over-year.
- Peak current liabilities per share was recorded in FY2014.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.33 | -32.5% |
| FY2018 | $0.48 | +81.4% |
| FY2017 | $0.27 | -26.5% |
| FY2016 | $0.36 | -49.8% |
| FY2015 | $0.72 | -92.4% |
| FY2014 | $9.46 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026